69 /100
HIGH RISK
Score updated May 30, 2026

KALA — KALA BIO, Inc. Dilution Risk Tracker

Track KALA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KALA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
90
💰 Cash Runway
85
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
30%
💰 Capital Raise 55%
• Low cash runway: 5 months remaining
• Active shelf registration ($350M, 844% of market cap)
📉 Score Deterioration 10%
• Score in HIGH risk zone (69/100)
🔔 Track KALA — Get forecast alerts →

💹 Market Data

Market Cap$41.46M
Shares Outstanding18.59M
Float18.59M
Cash$8.76M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 2.68M shares
#1 Baker Bros. Advisors, LP 1.80M shares
#2 Jane Street Group, LLC 144.3K shares
#3 Woodline Partners LP 224.2K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest42.6K
Days to Cover1.0
% of Float0.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2018
xbrl XBRL CONVERTIBLE Dec 31, 2017
S-3 SHELF May 07, 2026
8-K 8K EVENT Mar 04, 2026
424B3 ATM Feb 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

BC-Most Active Stocks Associated Press Finance · Mar 11
Top Midday Gainers MT Newswires · Dec 01
KALA BIO: Q3 Earnings Snapshot Associated Press Finance · Nov 19
Track KALA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KALA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for KALA
📊 KALA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 KALA Signal Convergence & Dark Pool Activity — StonkWhisper 📄 KALA Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.